+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Postbiotics Market by Product Type (Capsules, Liquids, Powders), Formulation (Encapsulated, Unencapsulated), Functionality, Packaging Type, Application, End-User, Distribution Channel - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 193 Pages
  • March 2025
  • Region: Global
  • 360iResearch™
  • ID: 5924776
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Postbiotics Market grew from USD 1.62 billion in 2024 to USD 1.74 billion in 2025. It is expected to continue growing at a CAGR of 7.41%, reaching USD 2.50 billion by 2030.

Postbiotics have emerged as a pivotal innovation in the evolving landscape of health and wellness. The advent of these biologically active compounds derived from post-fermentation processes has reshaped perspectives on both preventive and therapeutic approaches in human health. In recent years, scientific research has unveiled the multifaceted benefits of postbiotics, ranging from enhanced gut health to improved immune response, making them a critical area of interest for industry stakeholders.

This market overview delves into the origins and key developments that have propelled postbiotics into the limelight, highlighting their potential to influence consumer behavior and clinical outcomes. The fusion of cutting-edge research with tangible commercial applications underscores the critical role postbiotics now play, fostering an environment of innovation and growth. As market dynamics shift toward more holistic and targeted health solutions, postbiotics promise not only to drive health benefits but also to redefine industry standards and consumer expectations.

With an increasing emphasis on natural alternatives and scientifically validated health interventions, the strategic importance of postbiotics cannot be overstated. Decision-makers in both public and private sectors are investing in research, product development, and clinical trials to harness the promise of these compounds, ensuring that the market stays ahead of emerging health trends while addressing the broader needs of diverse consumer segments.

Transformative Shifts in the Market Landscape

The postbiotics market is undergoing a profound transformation driven by innovation, consumer demand, and scientific advancements. Recent shifts reflect a move from a traditional probiotics-centered perspective toward a more nuanced view that embraces the benefits of bacterial derivatives. This transformative trend is rooted in the increasing understanding of how postbiotics can deliver targeted health benefits without some of the side effects associated with live microorganisms.

A combination of technological breakthroughs, evolving regulatory standards, and improved clinical evidence has fostered an environment where postbiotics are gaining traction among both clinicians and consumers. Research laboratories around the globe are reconfiguring traditional methods to better isolate, stabilize, and administer these compounds, paving the way for products that offer precise health benefits. The shift is also propelled by consumer preference for products that not only promise improved digestive and immune health but also cater to specific lifestyle needs such as enhanced skin health and efficient weight management.

Moreover, industry experts are noting that enhanced stability during storage and transport as well as reduced contamination risks are crucial factors that have facilitated the acceptance of postbiotic solutions. The market is adjusting to these dynamics, which represents a departure from earlier paradigms that predominantly focused on live cultures. These changes are prompting a reexamination of formulations, packaging, application techniques, as well as distribution channels, collectively reinforcing the transformative impact of postbiotics on the global health sector.

Key Segmentation Insights for the Evolving Market

In today’s market, detailed segmentation provides an essential framework for understanding the diverse applications and technological nuances of postbiotics. The market is first dissected based on product type, where offerings range from capsules, liquids, powders, and tablets. Among these, liquids are scrutinized further into concentrated forms and ready-to-drink formulations, while tablets are explored through the lenses of both chewable and effervescent types. This segmentation aids in identifying the specific needs of different consumer groups and the contexts in which these products can be most effectively deployed.

Beyond product type, the market analysis extends to formulation, distinguishing solutions that are encapsulated from those that remain unencapsulated. This delineation is crucial because it directly influences the bioavailability and stability of the products. Furthermore, the market is stratified by functionality, which emphasizes the diverse health benefits delivered by postbiotics: spanning digestive health, immune support, skin health, and weight management. This functional categorization highlights the adaptability of postbiotics across various therapeutic domains and their ability to cater to both preventative and corrective health measures.

An additional layer of segmentation is evident when considering packaging type, where options such as bottles, sachets, and stick packs play a significant role. Within this framework, bottles are analyzed further in terms of glass and plastic origins, while sachets are expanded into multi-serving and single-use variants. These packaging distinctions influence consumer convenience, product longevity, and overall market appeal.

The segmentation continues to encompass application-specific categories, which include animal feed, food and beverages, personal care, and pharmaceuticals - the latter being dissected further into medicine drug formulations and probiotic supplements. This multi-tiered segmentation not only illustrates the expansive reach of postbiotics across industries but also provides a granular understanding of how each segment can be leveraged for optimal market penetration.

Additional insights derive from segmenting the market based on the end-user, capturing the nuances between adults, geriatrics, and pediatrics. This classification helps in tailoring both product formulations and marketing strategies to meet the unique needs of different demographic groups. Finally, distribution channels offer a rich layer of complexity, ranging from online stores to pharmacies and drug stores, specialty stores, and supermarkets and hypermarkets. Within the online space, further differentiation is made between e-commerce websites and subscription services, while specialty stores are refined into dietary supplement stores and health food stores. Supermarkets and hypermarkets are similarly categorized into sections that cater generally to health, as well as those focused on organic health offerings. Each of these segmentation dimensions reveals a complex interplay of consumer demand, technological evolution, and market dynamics that collectively constitute a rich tapestry of insights necessary for steering the future trajectory of the postbiotics market.

Based on Product Type, market is studied across Capsules, Liquids, Powders, and Tablets. The Liquids is further studied across Concentrated Liquids and Ready-To-Drink Liquids. The Tablets is further studied across Chewable Tablets and Effervescent Tablets.

Based on Formulation, market is studied across Encapsulated and Unencapsulated.

Based on Functionality, market is studied across Digestive Health, Immune Support, Skin Health, and Weight Management.

Based on Packaging Type, market is studied across Bottles, Sachets, and Stick Packs. The Bottles is further studied across Glass Bottles and Plastic Bottles. The Sachets is further studied across Multi-Serving Sachets and Single Use Sachets.

Based on Application, market is studied across Animal Feed, Food & Beverages, Personal Care, and Pharmaceuticals. The Pharmaceuticals is further studied across Medicine Drug Formulation and Probiotic Supplements.

Based on End-User, market is studied across Adults, Geriatrics, and Pediatrics.

Based on Distribution Channel, market is studied across Online Stores, Pharmacies & Drug Stores, Specialty Stores, and Supermarkets & Hypermarkets. The Online Stores is further studied across E-commerce Websites and Subscription Services. The Specialty Stores is further studied across Dietary Supplement Stores and Health Food Stores. The Supermarkets & Hypermarkets is further studied across General Health Sections and Organic Health Sections.

Key Regional Insights Shaping Market Opportunities

Geographical analysis of the postbiotics landscape highlights how region-specific trends are dictating market evolution. In the Americas, advanced healthcare infrastructure coupled with heightened consumer awareness of natural health solutions has spurred significant growth. Industry innovators in this region are capitalizing on the robust regulatory frameworks and a rapidly expanding market for natural therapeutics to boost research and product developments.

In the Europe, Middle East & Africa region, diverse demographic trends and a strong emphasis on traditional natural remedies are intersecting with modern scientific research to create a fertile market for postbiotic innovations. Here, regulatory bodies are increasingly supportive of research initiatives, thereby facilitating the emergence of novel products that seamlessly blend conventional wisdom with advanced technological insights. The region benefits from a deep historical understanding of natural health and wellness, which is now being augmented by clinical evidence and technological advancements.

Asia-Pacific, marked by a burgeoning middle class and rapid industrialization, is witnessing a dramatic shift in consumer preferences as awareness about holistic health measures grows. Increased investments in biotechnology and clinical research have positioned this region as a significant contributor to the global postbiotics market. The unique interplay of tradition and modernity here has fostered an environment where innovative formulations and comprehensive product portfolios are rapidly gaining acceptance. The convergence of cultural openness towards alternative therapies coupled with rigorous scientific validation is fostering new market entrants and promoting sustained growth across these diverse regions.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Key Companies Insights Driving Market Innovation

Market leadership is exemplified by a diverse group of companies that are at the forefront of innovation in the postbiotics space. Renowned enterprises such as Archer-Daniels-Midland Company, Beekeeper's Naturals, Inc., and Bioflag Group are setting high standards for product development and market penetration. Other major players like Cargill Incorporated, Dr. Emil Nutrition, LLC, DSM-Firmenich AG, and Essential Formulas Incorporated are similarly instrumental in pushing the boundaries of research and technological advancement.

This competitive landscape is further enriched by the contributions of GeneFerm Biotechnology Co., Ltd., Gundry MD, GutArmor by Get Wellness, LLC, and Healist Naturals, LLC, all of whom are extensively involved in groundbreaking research and formulation techniques. Ildong Pharmaceutical Co., Ltd., Kerry Group PLC, and Kirin Holdings Company, Limited are employing innovative distribution and marketing strategies that are reshaping consumer engagement. Additional influential entities such as L'Oréal S.A., Maypro Group, MCLS Europe B.V., and MRM Nutrition offer specialized solutions that align with consumer wellness trends.

Otemchi Biotechnologies Pte. Ltd., Phileo by Lesaffre, Postbiotics Inc., Probiotics Australia Pty., Ltd., Probioway Co., Ltd., and Puratos Group are contributing to an ever-expanding portfolio of postbiotic products, each enhancing the overall market mosaic. Leading voices in the market also include Sabinsa Corporation, Silab SA, woresan GmbH, and POSTBIOTICA S.R.L., whose strategic initiatives and innovative product lines are setting new benchmarks. The collective efforts of these companies underline a commitment to excellence and a determination to push the frontiers of what postbiotics can achieve in the context of modern nutrition and healthcare solutions.

The report delves into recent significant developments in the Postbiotics Market, highlighting leading vendors and their innovative profiles. These include Archer-Daniels-Midland Company, Beekeeper's Naturals, Inc., Bioflag Group, Cargill Incorporated, Dr. Emil Nutrition, LLC, DSM-Firmenich AG, Essential Formulas Incorporated, GeneFerm Biotechnology Co., Ltd., Gundry MD, GutArmor by Get Wellness, LLC, Healist Naturals, LLC, Ildong Pharmaceutical Co., Ltd., Kerry Group PLC, Kirin Holdings Company, Limited, L'Oréal S.A., Maypro Group, MCLS Europe B.V., MRM Nutrition, Otemchi Biotechnologies Pte. Ltd., Phileo by Lesaffre, Postbiotics Inc., Probiotics Australia Pty., Ltd., Probioway Co., Ltd., Puratos Group, Sabinsa Corporation, Silab SA, woresan GmbH, and ​POSTBIOTICA S.R.L..

Actionable Recommendations for Differentiating Market Leadership

Industry leaders are encouraged to adopt a multifaceted strategy aimed at leveraging emerging trends while addressing the challenges that characterize the dynamic postbiotics market. Firstly, an emphasis on enhanced research and development is critical; investing in advanced technologies and clinical trials can yield new insights into product efficacy and safety. Harnessing partnerships with academic institutions and biotech innovators can further accelerate the pace of technological advancement and ensure the development of next-generation formulations that meet rigorous quality standards.

Ongoing market analysis is another cornerstone of strategic success. Leaders should continually monitor consumer preferences, regulatory changes, and technological breakthroughs to rapidly adjust product portfolios and marketing strategies. By integrating data analytics and real-time market feedback, organizations can make informed decisions that drive swift adaptations to market shifts.

Operational efficiency is equally important; initiatives aimed at optimizing supply chain management, reducing costs, and ensuring timely product delivery are essential in the context of competitive global markets. Incorporating sustainable practices and environmentally friendly packaging not only meets consumer demands for greener products, but also positions companies as responsible stewards of both human and environmental health.

Moreover, there is a compelling need to enhance consumer engagement through targeted marketing and educational initiatives. By clearly communicating the benefits of postbiotics and demystifying their role in health and wellness, companies can build trust and foster long-term consumer loyalty. Engagement should extend beyond traditional media, using digital platforms to create interactive experiences that educate and inspire.

Finally, collaborative approaches in market expansion, including forming alliances with key stakeholders in distribution channels - from online platforms to traditional retail - ensure the product reaches a broader audience. Leaders must also focus on a diversified portfolio that spans various applications, from personal care and pharmaceuticals to food and beverages, thereby harnessing the full potential of postbiotic innovations and establishing a robust market presence.

Embracing the Future of Health with Postbiotics

The postbiotics market stands as a testament to the rapid evolution of health and wellness sectors underscored by scientific innovation and changing consumer paradigms. In this transformative era, the synthesis of rigorous research and progressive product development is not just redefining health strategies but also paving new avenues for sustainable growth and market resilience.

From comprehensive segmentation that elucidates product types, formulation strategies, functionalities, packaging, application nuances, end-user demographics, and distribution channels, it is clear that every aspect of the market is meticulously mapped to address modern health challenges. The regional insights affirm that across the Americas, Europe, Middle East & Africa, and Asia-Pacific, tailored approaches have led to substantial advancements and unprecedented opportunities. Simultaneously, the robust contributions of leading companies, each bringing unique strengths and strategies, are reinforcing the market’s foundation and stimulating continual innovation.

In broad terms, the interlinking of these key market dimensions has culminated in a dynamic ecosystem where innovation, consumer-centric strategies, and technological precision converge. The future of postbiotics is poised to not only capitalize on these trends but also to shape the industry by introducing novel solutions that improve health outcomes, foster consumer confidence, and establish new benchmarks for excellence in the health and wellness space.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing consumer awareness of gut health and its impact on overall well-being
5.1.1.2. Rising preference for natural and functional ingredients globally
5.1.2. Restraints
5.1.2.1. Concern associated with high production costs and limited commercial availability of postbiotics
5.1.3. Opportunities
5.1.3.1. Partnering with pharmaceutical companies to develop postbiotic formulations for digestive health
5.1.3.2. Integrating postbiotics into skincare to attract consumers seeking innovative cosmetic products
5.1.4. Challenges
5.1.4.1. Understanding regulatory hurdles and gaining market approvals is a crucial challenge for postbiotics
5.2. Market Segmentation Analysis
5.2.1. Product Type : High preference for capsules due to their convenience and precise dosages
5.2.2. Application : Rise in the usage of probiotic supplements owing to increasing self-medication trends and preventive healthcare approaches
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Postbiotics Market, by Product Type
6.1. Introduction
6.2. Capsules
6.3. Liquids
6.3.1. Concentrated Liquids
6.3.2. Ready-To-Drink Liquids
6.4. Powders
6.5. Tablets
6.5.1. Chewable Tablets
6.5.2. Effervescent Tablets
7. Postbiotics Market, by Formulation
7.1. Introduction
7.2. Encapsulated
7.3. Unencapsulated
8. Postbiotics Market, by Functionality
8.1. Introduction
8.2. Digestive Health
8.3. Immune Support
8.4. Skin Health
8.5. Weight Management
9. Postbiotics Market, by Packaging Type
9.1. Introduction
9.2. Bottles
9.2.1. Glass Bottles
9.2.2. Plastic Bottles
9.3. Sachets
9.3.1. Multi-Serving Sachets
9.3.2. Single Use Sachets
9.4. Stick Packs
10. Postbiotics Market, by Application
10.1. Introduction
10.2. Animal Feed
10.3. Food & Beverages
10.4. Personal Care
10.5. Pharmaceuticals
10.5.1. Medicine Drug Formulation
10.5.2. Probiotic Supplements
11. Postbiotics Market, by End-User
11.1. Introduction
11.2. Adults
11.3. Geriatrics
11.4. Pediatrics
12. Postbiotics Market, by Distribution Channel
12.1. Introduction
12.2. Online Stores
12.2.1. E-commerce Websites
12.2.2. Subscription Services
12.3. Pharmacies & Drug Stores
12.4. Specialty Stores
12.4.1. Dietary Supplement Stores
12.4.2. Health Food Stores
12.5. Supermarkets & Hypermarkets
12.5.1. General Health Sections
12.5.2. Organic Health Sections
13. Americas Postbiotics Market
13.1. Introduction
13.2. Argentina
13.3. Brazil
13.4. Canada
13.5. Mexico
13.6. United States
14. Asia-Pacific Postbiotics Market
14.1. Introduction
14.2. Australia
14.3. China
14.4. India
14.5. Indonesia
14.6. Japan
14.7. Malaysia
14.8. Philippines
14.9. Singapore
14.10. South Korea
14.11. Taiwan
14.12. Thailand
14.13. Vietnam
15. Europe, Middle East & Africa Postbiotics Market
15.1. Introduction
15.2. Denmark
15.3. Egypt
15.4. Finland
15.5. France
15.6. Germany
15.7. Israel
15.8. Italy
15.9. Netherlands
15.10. Nigeria
15.11. Norway
15.12. Poland
15.13. Qatar
15.14. Russia
15.15. Saudi Arabia
15.16. South Africa
15.17. Spain
15.18. Sweden
15.19. Switzerland
15.20. Turkey
15.21. United Arab Emirates
15.22. United Kingdom
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Scenario Analysis
16.3.1. Innovative ResM GLP-1 postbiotic harnesses physician-developed science to refine the Gut-X Axis and advance metabolic balance
16.3.2. Sabinsa and Postbiotics Inc. established a multinational distribution agreement for PoZibio
16.3.3. Sirio Pharma's launches GummiBiotics
16.3.4. Kerry Group introduces Plenibiotic, a novel rice-derived postbiotic to enhance digestive and skin health for humans and pets
16.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. POSTBIOTICS MARKET MULTI-CURRENCY
FIGURE 2. POSTBIOTICS MARKET MULTI-LANGUAGE
FIGURE 3. POSTBIOTICS MARKET RESEARCH PROCESS
FIGURE 4. POSTBIOTICS MARKET SIZE, 2024 VS 2030
FIGURE 5. GLOBAL POSTBIOTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 6. GLOBAL POSTBIOTICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL POSTBIOTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL POSTBIOTICS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 9. GLOBAL POSTBIOTICS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL POSTBIOTICS MARKET SIZE, BY FORMULATION, 2024 VS 2030 (%)
FIGURE 11. GLOBAL POSTBIOTICS MARKET SIZE, BY FORMULATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL POSTBIOTICS MARKET SIZE, BY FUNCTIONALITY, 2024 VS 2030 (%)
FIGURE 13. GLOBAL POSTBIOTICS MARKET SIZE, BY FUNCTIONALITY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 14. GLOBAL POSTBIOTICS MARKET SIZE, BY PACKAGING TYPE, 2024 VS 2030 (%)
FIGURE 15. GLOBAL POSTBIOTICS MARKET SIZE, BY PACKAGING TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 16. GLOBAL POSTBIOTICS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 17. GLOBAL POSTBIOTICS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 18. GLOBAL POSTBIOTICS MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
FIGURE 19. GLOBAL POSTBIOTICS MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 20. GLOBAL POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 21. GLOBAL POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 22. AMERICAS POSTBIOTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 23. AMERICAS POSTBIOTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 24. UNITED STATES POSTBIOTICS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 25. UNITED STATES POSTBIOTICS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 26. ASIA-PACIFIC POSTBIOTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 27. ASIA-PACIFIC POSTBIOTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 28. EUROPE, MIDDLE EAST & AFRICA POSTBIOTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 29. EUROPE, MIDDLE EAST & AFRICA POSTBIOTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 30. POSTBIOTICS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 31. POSTBIOTICS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. POSTBIOTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL POSTBIOTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL POSTBIOTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL POSTBIOTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. POSTBIOTICS MARKET DYNAMICS
TABLE 7. GLOBAL POSTBIOTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL POSTBIOTICS MARKET SIZE, BY CAPSULES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL POSTBIOTICS MARKET SIZE, BY LIQUIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL POSTBIOTICS MARKET SIZE, BY CONCENTRATED LIQUIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL POSTBIOTICS MARKET SIZE, BY READY-TO-DRINK LIQUIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL POSTBIOTICS MARKET SIZE, BY LIQUIDS, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL POSTBIOTICS MARKET SIZE, BY POWDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL POSTBIOTICS MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL POSTBIOTICS MARKET SIZE, BY CHEWABLE TABLETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL POSTBIOTICS MARKET SIZE, BY EFFERVESCENT TABLETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL POSTBIOTICS MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL POSTBIOTICS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL POSTBIOTICS MARKET SIZE, BY ENCAPSULATED, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL POSTBIOTICS MARKET SIZE, BY UNENCAPSULATED, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL POSTBIOTICS MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL POSTBIOTICS MARKET SIZE, BY DIGESTIVE HEALTH, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL POSTBIOTICS MARKET SIZE, BY IMMUNE SUPPORT, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL POSTBIOTICS MARKET SIZE, BY SKIN HEALTH, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL POSTBIOTICS MARKET SIZE, BY WEIGHT MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL POSTBIOTICS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL POSTBIOTICS MARKET SIZE, BY BOTTLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL POSTBIOTICS MARKET SIZE, BY GLASS BOTTLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL POSTBIOTICS MARKET SIZE, BY PLASTIC BOTTLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL POSTBIOTICS MARKET SIZE, BY BOTTLES, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL POSTBIOTICS MARKET SIZE, BY SACHETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL POSTBIOTICS MARKET SIZE, BY MULTI-SERVING SACHETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL POSTBIOTICS MARKET SIZE, BY SINGLE USE SACHETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL POSTBIOTICS MARKET SIZE, BY SACHETS, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL POSTBIOTICS MARKET SIZE, BY STICK PACKS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL POSTBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL POSTBIOTICS MARKET SIZE, BY ANIMAL FEED, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL POSTBIOTICS MARKET SIZE, BY FOOD & BEVERAGES, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL POSTBIOTICS MARKET SIZE, BY PERSONAL CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL POSTBIOTICS MARKET SIZE, BY PHARMACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL POSTBIOTICS MARKET SIZE, BY MEDICINE DRUG FORMULATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL POSTBIOTICS MARKET SIZE, BY PROBIOTIC SUPPLEMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL POSTBIOTICS MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL POSTBIOTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL POSTBIOTICS MARKET SIZE, BY ADULTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL POSTBIOTICS MARKET SIZE, BY GERIATRICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL POSTBIOTICS MARKET SIZE, BY PEDIATRICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL POSTBIOTICS MARKET SIZE, BY ONLINE STORES, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL POSTBIOTICS MARKET SIZE, BY E-COMMERCE WEBSITES, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL POSTBIOTICS MARKET SIZE, BY SUBSCRIPTION SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL POSTBIOTICS MARKET SIZE, BY ONLINE STORES, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL POSTBIOTICS MARKET SIZE, BY PHARMACIES & DRUG STORES, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL POSTBIOTICS MARKET SIZE, BY SPECIALTY STORES, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL POSTBIOTICS MARKET SIZE, BY DIETARY SUPPLEMENT STORES, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL POSTBIOTICS MARKET SIZE, BY HEALTH FOOD STORES, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL POSTBIOTICS MARKET SIZE, BY SPECIALTY STORES, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL POSTBIOTICS MARKET SIZE, BY SUPERMARKETS & HYPERMARKETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL POSTBIOTICS MARKET SIZE, BY GENERAL HEALTH SECTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL POSTBIOTICS MARKET SIZE, BY ORGANIC HEALTH SECTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL POSTBIOTICS MARKET SIZE, BY SUPERMARKETS & HYPERMARKETS, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS POSTBIOTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS POSTBIOTICS MARKET SIZE, BY LIQUIDS, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS POSTBIOTICS MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS POSTBIOTICS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS POSTBIOTICS MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS POSTBIOTICS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS POSTBIOTICS MARKET SIZE, BY BOTTLES, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS POSTBIOTICS MARKET SIZE, BY SACHETS, 2018-2030 (USD MILLION)
TABLE 70. AMERICAS POSTBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 71. AMERICAS POSTBIOTICS MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 72. AMERICAS POSTBIOTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 73. AMERICAS POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 74. AMERICAS POSTBIOTICS MARKET SIZE, BY ONLINE STORES, 2018-2030 (USD MILLION)
TABLE 75. AMERICAS POSTBIOTICS MARKET SIZE, BY SPECIALTY STORES, 2018-2030 (USD MILLION)
TABLE 76. AMERICAS POSTBIOTICS MARKET SIZE, BY SUPERMARKETS & HYPERMARKETS, 2018-2030 (USD MILLION)
TABLE 77. AMERICAS POSTBIOTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 78. ARGENTINA POSTBIOTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 79. ARGENTINA POSTBIOTICS MARKET SIZE, BY LIQUIDS, 2018-2030 (USD MILLION)
TABLE 80. ARGENTINA POSTBIOTICS MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
TABLE 81. ARGENTINA POSTBIOTICS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 82. ARGENTINA POSTBIOTICS MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 83. ARGENTINA POSTBIOTICS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 84. ARGENTINA POSTBIOTICS MARKET SIZE, BY BOTTLES, 2018-2030 (USD MILLION)
TABLE 85. ARGENTINA POSTBIOTICS MARKET SIZE, BY SACHETS, 2018-2030 (USD MILLION)
TABLE 86. ARGENTINA POSTBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 87. ARGENTINA POSTBIOTICS MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 88. ARGENTINA POSTBIOTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 89. ARGENTINA POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 90. ARGENTINA POSTBIOTICS MARKET SIZE, BY ONLINE STORES, 2018-2030 (USD MILLION)
TABLE 91. ARGENTINA POSTBIOTICS MARKET SIZE, BY SPECIALTY STORES, 2018-2030 (USD MILLION)
TABLE 92. ARGENTINA POSTBIOTICS MARKET SIZE, BY SUPERMARKETS & HYPERMARKETS, 2018-2030 (USD MILLION)
TABLE 93. BRAZIL POSTBIOTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 94. BRAZIL POSTBIOTICS MARKET SIZE, BY LIQUIDS, 2018-2030 (USD MILLION)
TABLE 95. BRAZIL POSTBIOTICS MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
TABLE 96. BRAZIL POSTBIOTICS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 97. BRAZIL POSTBIOTICS MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 98. BRAZIL POSTBIOTICS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 99. BRAZIL POSTBIOTICS MARKET SIZE, BY BOTTLES, 2018-2030 (USD MILLION)
TABLE 100. BRAZIL POSTBIOTICS MARKET SIZE, BY SACHETS, 2018-2030 (USD MILLION)
TABLE 101. BRAZIL POSTBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 102. BRAZIL POSTBIOTICS MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 103. BRAZIL POSTBIOTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 104. BRAZIL POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 105. BRAZIL POSTBIOTICS MARKET SIZE, BY ONLINE STORES, 2018-2030 (USD MILLION)
TABLE 106. BRAZIL POSTBIOTICS MARKET SIZE, BY SPECIALTY STORES, 2018-2030 (USD MILLION)
TABLE 107. BRAZIL POSTBIOTICS MARKET SIZE, BY SUPERMARKETS & HYPERMARKETS, 2018-2030 (USD MILLION)
TABLE 108. CANADA POSTBIOTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 109. CANADA POSTBIOTICS MARKET SIZE, BY LIQUIDS, 2018-2030 (USD MILLION)
TABLE 110. CANADA POSTBIOTICS MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
TABLE 111. CANADA POSTBIOTICS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 112. CANADA POSTBIOTICS MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 113. CANADA POSTBIOTICS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 114. CANADA POSTBIOTICS MARKET SIZE, BY BOTTLES, 2018-2030 (USD MILLION)
TABLE 115. CANADA POSTBIOTICS MARKET SIZE, BY SACHETS, 2018-2030 (USD MILLION)
TABLE 116. CANADA POSTBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 117. CANADA POSTBIOTICS MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 118. CANADA POSTBIOTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 119. CANADA POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 120. CANADA POSTBIOTICS MARKET SIZE, BY ONLINE STORES, 2018-2030 (USD MILLION)
TABLE 121. CANADA POSTBIOTICS MARKET SIZE, BY SPECIALTY STORES, 2018-2030 (USD MILLION)
TABLE 122. CANADA POSTBIOTICS MARKET SIZE, BY SUPERMARKETS & HYPERMARKETS, 2018-2030 (USD MILLION)
TABLE 123. MEXICO POSTBIOTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 124. MEXICO POSTBIOTICS MARKET SIZE, BY LIQUIDS, 2018-2030 (USD MILLION)
TABLE 125. MEXICO POSTBIOTICS MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
TABLE 126. MEXICO POSTBIOTICS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 127. MEXICO POSTBIOTICS MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 128. MEXICO POSTBIOTICS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 129. MEXICO POSTBIOTICS MARKET SIZE, BY BOTTLES, 2018-2030 (USD MILLION)
TABLE 130. MEXICO POSTBIOTICS MARKET SIZE, BY SACHETS, 2018-2030 (USD MILLION)
TABLE 131. MEXICO POSTBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 132. MEXICO POSTBIOTICS MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 133. MEXICO POSTBIOTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 134. MEXICO POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 135. MEXICO POSTBIOTICS MARKET SIZE, BY ONLINE STORES, 2018-2030 (USD MILLION)
TABLE 136. MEXICO POSTBIOTICS MARKET SIZE, BY SPECIALTY STORES, 2018-2030 (USD MILLION)
TABLE 137. MEXICO POSTBIOTICS MARKET SIZE, BY SUPERMARKETS & HYPERMARKETS, 2018-2030 (USD MILLION)
TABLE 138. UNITED STATES POSTBIOTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 139. UNITED STATES POSTBIOTICS MARKET SIZE, BY LIQUIDS, 2018-2030 (USD MILLION)
TABLE 140. UNITED STATES POSTBIOTICS MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
TABLE 141. UNITED STATES POSTBIOTICS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 142. UNITED STATES POSTBIOTICS MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 143. UNITED STATES POSTBIOTICS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 144. UNITED STATES POSTBIOTICS MARKET SIZE, BY BOTTLES, 2018-2030 (USD MILLION)
TABLE 145. UNITED STATES POSTBIOTICS MARKET SIZE, BY SACHETS, 2018-2030 (USD MILLION)
TABLE 146. UNITED STATES POSTBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 147. UNITED STATES POSTBIOTICS MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 148. UNITED STATES POSTBIOTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 149. UNITED STATES POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 150. UNITED STATES POSTBIOTICS MARKET SIZE, BY ONLINE STORES, 2018-2030 (USD MILLION)
TABLE 151. UNITED STATES POSTBIOTICS MARKET SIZE, BY SPECIALTY STORES, 2018-2030 (USD MILLION)
TABLE 152. UNITED STATES POSTBIOTICS MARKET SIZE, BY SUPERMARKETS & HYPERMARKETS, 2018-2030 (USD MILLION)
TABLE 153. UNITED STATES POSTBIOTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 154. ASIA-PACIFIC POSTBIOTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 155. ASIA-PACIFIC POSTBIOTICS MARKET SIZE, BY LIQUIDS, 2018-2030 (USD MILLION)
TABLE 156. ASIA-PACIFIC POSTBIOTICS MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
TABLE 157. ASIA-PACIFIC POSTBIOTICS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 158. ASIA-PACIFIC POSTBIOTICS MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 159. ASIA-PACIFIC POSTBIOTICS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 160. ASIA-PACIFIC POSTBIOTICS MARKET SIZE, BY BOTTLES, 2018-2030 (USD MILLION)
TABLE 161. ASIA-PACIFIC POSTBIOTICS MARKET SIZE, BY SACHETS, 2018-2030 (USD MILLION)
TABLE 162. ASIA-PACIFIC POSTBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 163. ASIA-PACIFIC POSTBIOTICS MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 164. ASIA-PACIFIC POSTBIOTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 165. ASIA-PACIFIC POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 166. ASIA-PACIFIC POSTBIOTICS MARKET SIZE, BY ONLINE STORES, 2018-2030 (USD MILLION)
TABLE 167. ASIA-PACIFIC POSTBIOTICS MARKET SIZE, BY SPECIALTY STORES, 2018-2030 (USD MILLION)
TABLE 168. ASIA-PACIFIC POSTBIOTICS MARKET SIZE, BY SUPERMARKETS & HYPERMARKETS, 2018-2030 (USD MILLION)
TABLE 169. ASIA-PACIFIC POSTBIOTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 170. AUSTRALIA POSTBIOTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 171. AUSTRALIA POSTBIOTICS MARKET SIZE, BY LIQUIDS, 2018-2030 (USD MILLION)
TABLE 172. AUSTRALIA POSTBIOTICS MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
TABLE 173. AUSTRALIA POSTBIOTICS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 174. AUSTRALIA POSTBIOTICS MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 175. AUSTRALIA POSTBIOTICS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 176. AUSTRALIA POSTBIOTICS MARKET SIZE, BY BOTTLES, 2018-2030 (USD MILLION)
TABLE 177. AUSTRALIA POSTBIOTICS MARKET SIZE, BY SACHETS, 2018-2030 (USD MILLION)
TABLE 178. AUSTRALIA POSTBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 179. AUSTRALIA POSTBIOTICS MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 180. AUSTRALIA POSTBIOTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 181. AUSTRALIA POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 182. AUSTRALIA POSTBIOTICS MARKET SIZE, BY ONLINE STORES, 2018-2030 (USD MILLION)
TABLE 183. AUSTRALIA POSTBIOTICS MARKET SIZE, BY SPECIALTY STORES, 2018-2030 (USD MILLION)
TABLE 184. AUSTRALIA POSTBIOTICS MARKET SIZE, BY SUPERMARKETS & HYPERMARKETS, 2018-2030 (USD MILLION)
TABLE 185. CHINA POSTBIOTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 186. CHINA POSTBIOTICS MARKET SIZE, BY LIQUIDS, 2018-2030 (USD MILLION)
TABLE 187. CHINA POSTBIOTICS MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
TABLE 188. CHINA POSTBIOTICS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 189. CHINA POSTBIOTICS MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 190. CHINA POSTBIOTICS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 191. CHINA POSTBIOTICS MARKET SIZE, BY BOTTLES, 2018-2030 (USD MILLION)
TABLE 192. CHINA POSTBIOTICS MARKET SIZE, BY SACHETS, 2018-2030 (USD MILLION)
TABLE 193. CHINA POSTBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 194. CHINA POSTBIOTICS MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 195. CHINA POSTBIOTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 196. CHINA POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 197. CHINA POSTBIOTICS MARKET SIZE, BY ONLINE STORES, 2018-2030 (USD MILLION)
TABLE 198. CHINA POSTBIOTICS MARKET SIZE, BY SPECIALTY STORES, 2018-2030 (USD MILLION)
TABLE 199. CHINA POSTBIOTICS MARKET SIZE, BY SUPERMARKETS & HYPERMARKETS, 2018-2030 (USD MILLION)
TABLE 200. INDIA POSTBIOTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 201. INDIA POSTBIOTICS MARKET SIZE, BY LIQUIDS, 2018-2030 (USD MILLION)
TABLE 202. INDIA POSTBIOTICS MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
TABLE 203. INDIA POSTBIOTICS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 204. INDIA POSTBIOTICS MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 205. INDIA POSTBIOTICS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 206. INDIA POSTBIOTICS MARKET SIZE, BY BOTTLES, 2018-2030 (USD MILLION)
TABLE 207. INDIA POSTBIOTICS MARKET SIZE, BY SACHETS, 2018-2030 (USD MILLION)
TABLE 208. INDIA POSTBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 209. INDIA POSTBIOTICS MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 210. INDIA POSTBIOTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 211. INDIA POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 212. INDIA POSTBIOTICS MARKET SIZE, BY ONLINE STORES, 2018-2030 (USD MILLION)
TABLE 213. INDIA POSTBIOTICS MARKET SIZE, BY SPECIALTY STORES, 2018-2030 (USD MILLION)
TABLE 214. INDIA POSTBIOTICS MARKET SIZE, BY SUPERMARKETS & HYPERMARKETS, 2018-2030 (USD MILLION)
TABLE 215. INDONESIA POSTBIOTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 216. INDONESIA POSTBIOTICS MARKET SIZE, BY LIQUIDS, 2018-2030 (USD MILLION)
TABLE 217. INDONESIA POSTBIOTICS MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
TABLE 218. INDONESIA POSTBIOTICS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 219. INDONESIA POSTBIOTICS MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 220. INDONESIA POSTBIOTICS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 221. INDONESIA POSTBIOTICS MARKET SIZE, BY BOTTLES, 2018-2030 (USD MILLION)
TABLE 222. INDONESIA POSTBIOTICS MARKET SIZE, BY SACHETS, 2018-2030 (USD MILLION)
TABLE 223. INDONESIA POSTBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 224. INDONESIA POSTBIOTICS MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 225. INDONESIA POSTBIOTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 226. INDONESIA POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 227. INDONESIA POSTBIOTICS MARKET SIZE, BY ONLINE STORES, 2018-2030 (USD MILLION)
TABLE 228. INDONESIA POSTBIOTICS MARKET SIZE, BY SPECIALTY STORES, 2018-2030 (USD MILLION)
TABLE 229. INDONESIA POSTBIOTICS MARKET SIZE, BY SUPERMARKETS & HYPERMARKETS, 2018-2030 (USD MILLION)
TABLE 230. JAPAN POSTBIOTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 231. JAPAN POSTBIOTICS MARKET SIZE, BY LIQUIDS, 2018-2030 (USD MILLION)
TABLE 232. JAPAN POSTBIOTICS MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
TABLE 233. JAPAN POSTBIOTICS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 234. JAPAN POSTBIOTICS MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 235. JAPAN POSTBIOTICS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 236. JAPAN POSTBIOTICS MARKET SIZE, BY BOTTLES, 2018-2030 (USD MILLION)
TABLE 237. JAPAN POSTBIOTICS MARKET SIZE, BY SACHETS, 2018-2030 (USD MILLION)
TABLE 238. JAPAN POSTBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 239. JAPAN POSTBIOTICS MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 240. JAPAN POSTBIOTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 241. JAPAN POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 242. JAPAN POSTBIOTICS MARKET SIZE, BY ONLINE STORES, 2018-2030 (USD MILLION)
TABLE 243. JAPAN POSTBIOTICS MARKET SIZE, BY SPECIALTY STORES, 2018-2030 (USD MILLION)
TABLE 244. JAPAN POSTBIOTICS MARKET SIZE, BY SUPERMARKETS & HYPERMARKETS, 2018-2030 (USD MILLION)
TABLE 245. MALAYSIA POSTBIOTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 246. MALAYSIA POSTBIOTICS MARKET SIZE, BY LIQUIDS, 2018-2030 (USD MILLION)
TABLE 247. MALAYSIA POSTBIOTICS MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
TABLE 248. MALAYSIA POSTBIOTICS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 249. MALAYSIA POSTBIOTICS MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 250. MALAYSIA POSTBIOTICS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 251. MALAYSIA POSTBIOTICS MARKET SIZE, BY BOTTLES, 2018-2030 (USD MILLION)
TABLE 252. MALAYSIA POSTBIOTICS MARKET SIZE, BY SACHETS, 2018-2030 (USD MILLION)
TABLE 253. MALAYSIA POSTBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 254. MALAYSIA POSTBIOTICS MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 255. MALAYSIA POSTBIOTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 256. MALAYSIA POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 257. MALAYSIA POSTBIOTICS MARKET SIZE, BY ONLINE STORES, 2018-2030 (USD MILLION)
TABLE 258. MALAYSIA POSTBIOTICS MARKET SIZE, BY SPECIALTY STORES, 2018-2030 (USD MILLION)
TABLE 259. MALAYSIA POSTBIOTICS MARKET SIZE, BY SUPERMARKETS & HYPERMARKETS, 2018-2030 (USD MILLION)
TABLE 260. PHILIPPINES POSTBIOTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 261. PHILIPPINES POSTBIOTICS MARKET SIZE, BY LIQUIDS, 2018-2030 (USD MILLION)
TABLE 262. PHILIPPINES POSTBIOTICS MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
TABLE 263. PHILIPPINES POSTBIOTICS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 264. PHILIPPINES POSTBIOTICS MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 265. PHILIPPINES POSTBIOTICS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 266. PHILIPPINES POSTBIOTICS MARKET SIZE, BY BOTTLES, 2018-2030 (USD MILLION)
TABLE 267. PHILIPPINES POSTBIOTICS MARKET SIZE, BY SACHETS, 2018-2030 (USD MILLION)
TABLE 268. PHILIPPINES POSTBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 269. PHILIPPINES POSTBIOTICS MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 270. PHILIPPINES POSTBIOTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 271. PHILIPPINES POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 272. PHILIPPINES POSTBIOTICS MARKET SIZE, BY ONLINE STORES, 2018-2030 (USD MILLION)
TABLE 273. PHILIPPINES POSTBIOTICS MARKET SIZE, BY SPECIALTY STORES, 2018-2030 (USD MILLION)
TABLE 274. PHILIPPINES POSTBIOTICS MARKET SIZE, BY SUPERMARKETS & HYPERMARKETS, 2018-2030 (USD MILLION)
TABLE 275. SINGAPORE POSTBIOTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 276. SINGAPORE POSTBIOTICS MARKET SIZE, BY LIQUIDS, 2018-2030 (USD MILLION)
TABLE 277. SINGAPORE POSTBIOTICS MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
TABLE 278. SINGAPORE POSTBIOTICS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 279. SINGAPORE POSTBIOTICS MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 280. SINGAPORE POSTBIOTICS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 281. SINGAPORE POSTBIOTICS MARKET SIZE, BY BOTTLES, 2018-2030 (USD MILLION)
TABLE 282. SINGAPORE POSTBIOTICS MARKET SIZE, BY SACHETS, 2018-2030 (USD MILLION)
TABLE 283. SINGAPORE POSTBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 284. SINGAPORE POSTBIOTICS MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 285. SINGAPORE POSTBIOTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 286. SINGAPORE POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 287. SINGAPORE POSTBIOTICS MARKET SIZE, BY ONLINE STORES, 2018-2030 (USD MILLION)
TABLE 288. SINGAPORE POSTBIOTICS MARKET SIZE, BY SPECIALTY STORES, 2018-2030 (USD MILLION)
TABLE 289. SINGAPORE POSTBIOTICS MARKET SIZE, BY SUPERMARKETS & HYPERMARKETS, 2018-2030 (USD MILLION)
TABLE 290. SOUTH KOREA POSTBIOTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 291. SOUTH KOREA POSTBIOTICS MARKET SIZE, BY LIQUIDS, 2018-2030 (USD MILLION)
TABLE 292. SOUTH KOREA POSTBIOTICS MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
TABLE 293. SOUTH KOREA POSTBIOTICS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 294. SOUTH KOREA POSTBIOTICS MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 295. SOUTH KOREA POSTBIOTICS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 296. SOUTH KOREA POSTBIOTICS MARKET SIZE, BY BOTTLES, 2018-2030 (USD MILLION)
TABLE 297. SOUTH KOREA POSTBIOTICS MARKET SIZE, BY SACHETS, 2018-2030 (USD MILLION)
TABLE 298. SOUTH KOREA POSTBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 299. SOUTH KOREA POSTBIOTICS MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 300. SOUTH KOREA POSTBIOTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 301. SOUTH KOREA POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 302. SOUTH KOREA POSTBIOTICS MARKET SIZE, BY ONLINE STORES, 2018-2030 (USD MILLION)
TABLE 303. SOUTH KOREA POSTBIOTICS MARKET SIZE, BY SPECIALTY STORES, 2018-2030 (USD MILLION)
TABLE 304. SOUTH KOREA POSTBIOTICS MARKET SIZE, BY SUPERMARKETS & HYPERMARKETS, 2018-2030 (USD MILLION)
TABLE 305. TAIWAN POSTBIOTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 306. TAIWAN POSTBIOTICS MARKET SIZE, BY LIQUIDS, 2018-2030 (USD MILLION)
TABLE 307. TAIWAN POSTBIOTICS MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
TABLE 308. TAIWAN POSTBIOTICS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 309. TAIWAN POSTBIOTICS MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 310. TAIWAN POSTBIOTICS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 311. TAIWAN POSTBIOTICS MARKET SIZE, BY BOTTLES, 2018-2030 (USD MILLION)
TABLE 312. TAIWAN POSTBIOTICS MARKET SIZE, BY SACHETS, 2018-2030 (USD MILLION)
TABLE 313. TAIWAN POSTBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 314. TAIWAN POSTBIOTICS MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 315. TAIWAN POSTBIOTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 316. TAIWAN POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 317. TAIWAN POSTBIOTICS MARKET SIZE, BY ONLINE STORES, 2018-2030 (USD MILLION)
TABLE 318. TAIWAN POSTBIOTICS MARKET SIZE, BY SPECIALTY STORES, 2018-2030 (USD MILLION)
TABLE 319. TAIWAN POSTBIOTICS MARKET SIZE, BY SUPERMARKETS & HYPERMARKETS, 2018-2030 (USD MILLION)
TABLE 320. THAILAND POSTBIOTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 321. THAILAND POSTBIOTICS MARKET SIZE, BY LIQUIDS, 2018-2030 (USD MILLION)
TABLE 322. THAILAND POSTBIOTICS MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
TABLE 323. THAILAND POSTBIOTICS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 324. THAILAND POSTBIOTICS MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 325. THAILAND POSTBIOTICS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 326. THAILAND POSTBIOTICS MARKET SIZE, BY BOTTLES, 2018-2030 (USD MILLION)
TABLE 327. THAILAND POSTBIOTICS MARKET SIZE, BY SACHETS, 2018-2030 (USD MILLION)
TABLE 328. THAILAND POSTBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 329. THAILAND POSTBIOTICS MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 330. THAILAND POSTBIOTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 331. THAILAND POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 332. THAILAND POSTBIOTICS MARKET SIZE, BY ONLINE STORES, 2018-2030 (USD MILLION)
TABLE 333. THAILAND POSTBIOTICS MARKET SIZE, BY SPECIALTY STORES, 2018-2030 (USD MILLION)
TABLE 334. THAILAND POSTBIOTICS MARKET SIZE, BY SUPERMARKETS & HYPERMARKETS, 2018-2030 (USD MILLION)
TABLE 335. VIETNAM POSTBIOTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 336. VIETNAM POSTBIOTICS MARKET SIZE, BY LIQUIDS, 2018-2030 (USD MILLION)
TABLE 337. VIETNAM POSTBIOTICS MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
TABLE 338. VIETNAM POSTBIOTICS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 339. VIETNAM POSTBIOTICS MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 340. VIETNAM POSTBIOTICS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 341. VIETNAM POSTBIOTICS MARKET SIZE, BY BOTTLES, 2018-2030 (USD MILLION)
TABLE 342. VIETNAM POSTBIOTICS MARKET SIZE, BY SACHETS, 2018-2030 (USD MILLION)
TABLE 343. VIETNAM POSTBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 344. VIETNAM POSTBIOTICS MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 345. VIETNAM POSTBIOTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 346. VIETNAM POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 347. VIETNAM POSTBIOTICS MARKET SIZE, BY ONLINE STORES, 2018-2030 (USD MILLION)
TABLE 348. VIETNAM POSTBIOTICS MARKET SIZE, BY SPECIALTY STORES, 2018-2030 (USD MILLION)
TABLE 349. VIETNAM POSTBIOTICS MARKET SIZE, BY SUPERMARKETS & HYPERMARKETS, 2018-2030 (USD MILLION)
TABLE 350. EUROPE, MIDDLE EAST & AFRICA POSTBIOTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 351. EUROPE, MIDDLE EAST & AFRICA POSTBIOTICS MARKET SIZE, BY LIQUIDS, 2018-2030 (USD MILLION)
TABLE 352. EUROPE, MIDDLE EAST & AFRICA POSTBIOTICS MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
TABLE 353. EUROPE, MIDDLE EAST & AFRICA POSTBIOTICS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 354. EUROPE, MIDDLE EAST & AFRICA POSTBIOTICS MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 355. EUROPE, MIDDLE EAST & AFRICA POSTBIOTICS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 356. EUROPE, MIDDLE EAST & AFRICA POSTBIOTICS MARKET SIZE, BY BOTTLES, 2018-2030 (USD MILLION)
TABLE 357. EUROPE, MIDDLE EAST & AFRICA POSTBIOTICS MARKET SIZE, BY SACHETS, 2018-2030 (USD MILLION)
TABLE 358. EUROPE, MIDDLE EAST & AFRICA POSTBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 359. EUROPE, MIDDLE EAST & AFRICA POSTBIOTICS MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 360. EUROPE, MIDDLE EAST & AFRICA POSTBIOTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 361. EUROPE, MIDDLE EAST & AFRICA POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 362. EUROPE, MIDDLE EAST & AFRICA POSTBIOTICS MARKET SIZE, BY ONLINE STORES, 2018-2030 (USD MILLION)
TABLE 363. EUROPE, MIDDLE EAST & AFRICA POSTBIOTICS MARKET SIZE, BY SPECIALTY STORES, 2018-2030 (USD MILLION)
TABLE 364. EUROPE, MIDDLE EAST & AFRICA POSTBIOTICS MARKET SIZE, BY SUPERMARKETS & HYPERMARKETS, 2018-2030 (USD MILLION)
TABLE 365. EUROPE, MIDDLE EAST & AFRICA POSTBIOTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 366. DENMARK POSTBIOTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 367. DENMARK POSTBIOTICS MARKET SIZE, BY LIQUIDS, 2018-2030 (USD MILLION)
TABLE 368. DENMARK POSTBIOTICS MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
TABLE 369. DENMARK POSTBIOTICS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 370. DENMARK POSTBIOTICS MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 371. DENMARK POSTBIOTICS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 372. DENMARK POSTBIOTICS MARKET SIZE, BY BOTTLES, 2018-2030 (USD MILLION)
TABLE 373. DENMARK POSTBIOTICS MARKET SIZE, BY SACHETS, 2018-2030 (USD MILLION)
TABL

Companies Mentioned

  • Archer-Daniels-Midland Company
  • Beekeeper's Naturals, Inc.
  • Bioflag Group
  • Cargill Incorporated
  • Dr. Emil Nutrition, LLC
  • DSM-Firmenich AG
  • Essential Formulas Incorporated
  • GeneFerm Biotechnology Co., Ltd.
  • Gundry MD
  • GutArmor by Get Wellness, LLC
  • Healist Naturals, LLC
  • Ildong Pharmaceutical Co., Ltd.
  • Kerry Group PLC
  • Kirin Holdings Company, Limited
  • L'Oréal S.A.
  • Maypro Group
  • MCLS Europe B.V.
  • MRM Nutrition
  • Otemchi Biotechnologies Pte. Ltd.
  • Phileo by Lesaffre
  • Postbiotics Inc.
  • Probiotics Australia Pty., Ltd.
  • Probioway Co., Ltd.
  • Puratos Group
  • Sabinsa Corporation
  • Silab SA
  • woresan GmbH
  • ​POSTBIOTICA S.R.L.

Methodology

Loading
LOADING...

Table Information